Skip to main content

Table 1 Characteristics of studies investigating the relationship between systemic immune-inflammation index (SII) and PCI

From: Systemic immune-inflammation index as a novel predictor of major adverse cardiovascular events in patients undergoing percutaneous coronary intervention: a meta-analysis of cohort studies

Study

Country

Year

Involved centers

Design

SII analysis

SII cut-off value

Age(mean + SD)

Sample

size

HTN%

DM%

HPL%

Follow-up

duration

(days)

Outcome

Ya-Ling Yang

china

2020

single

RC

High SII: Low SII

694.3

69.2 ± 12.9

5602

87

40

NA

1638

Demet Ozkaramanli Gur

Turkey

2021

single

RC

T3:T1

NA

64.15 ± 11,56

206

36

40

43

365

Sanling Shi

china

2022

single

RC

High SII: Low SII

1159.84

71.9 + 10.7

744

77

40

49

912.5

Gokhan Demirci

Turkey

2023

single

RC

High SII: Low SII

548

63.6 ± 9.1

303

78

44

56

10,095

Faysal Saylik

Turkey

2021

single

RC

High SII: Low SII

951.7

60.2 ± 9.74

843

33

24

39

1026

Lütfi Öcal

Turkey

2021

single

RC

High SII: Low SII

1781

56.93 ± 11.53

1660

42

22

27

999

Wenjun Fan

china

2021

single

PC

High SII: Low SII

628.60

NA

1553

59

25

22

1142

Xing Wei

china

2023

single

RC

T3:T1

1,085.55

62.54 ± 13.76

310

58

31

NA

NA

  1. MACEs, all-cause mortality, non-fatal stroke, non-fatal MI, heart failure, repeat revascularization
  2. Abbreviations: SII systemic immune-inflammation index, RC Retrospective cohort, ACS acute coronary syndrome, DM diabetes, HTN hypertension, HPL hyperlipidemia, PCI percutaneous coronary intervention, STEMI ST­segment elevation myocardial infarction, NSTEMI Non-ST-segment elevation myocardial infarction